A new investigational drug called apitegromab is being explored to preserve muscle mass in adults receiving glucagon-like peptide‑1 (GLP‑1) receptor agonists for obesity. The BBC has reported on a Nature Medicine study
Skeletal muscle is a dynamic, metabolically active organ essential for maintaining health throughout the lifespan. Beyond providing strength and locomotion, muscle regulates glucose metabolism, supports immune signalling and contributes to endocrine communication through the secretion of myokines.1 A decline in …
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
